Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle

BackgroundSkeletal muscles are composed of heterogeneous collections of muscle fiber types, the arrangement of which contributes to a variety of functional capabilities in many muscle types. Furthermore, skeletal muscles can adapt individual myofibers under various circumstances, such as disease and exercise, by changing fiber types. This study was performed to examine the influence of dystrophin deficiency on fiber type composition of skeletal muscles in canine X-linked muscular dystrophy in Japan (CXMDJ), a large animal model for Duchenne muscular dystrophy.MethodsWe used tibialis cranialis (TC) muscles and diaphragms of normal dogs and those with CXMDJ at various ages from 1 month to 3 years old. For classification of fiber types, muscle sections were immunostained with antibodies against fast, slow, or developmental myosin heavy chain (MHC), and the number and size of these fibers were analyzed. In addition, MHC isoforms were detected by gel electrophoresis.ResultsIn comparison with TC muscles of CXMDJ, the number of fibers expressing slow MHC increased markedly and the number of fibers expressing fast MHC decreased with growth in the affected diaphragm. In populations of muscle fibers expressing fast and/or slow MHC(s) but not developmental MHC of CXMDJ muscles, slow MHC fibers were predominant in number and showed selective enlargement. Especially, in CXMDJ diaphragms, the proportions of slow MHC fibers were significantly larger in populations of myofibers with non-expression of developmental MHC. Analyses of MHC isoforms also indicated a marked increase of type I and decrease of type IIA isoforms in the affected diaphragm at ages over 6 months. In addition, expression of developmental (embryonic and/or neonatal) MHC decreased in the CXMDJ diaphragm in adults, in contrast to continuous high-level expression in affected TC muscle.ConclusionThe CXMDJ diaphragm showed marked changes in fiber type composition unlike TC muscles, suggesting that the affected diaphragm may be effectively adapted toward dystrophic stress by switching to predominantly slow fibers. Furthermore, the MHC expression profile in the CXMDJ diaphragm was markedly different from that in mdx mice, indicating that the dystrophic dog is a more appropriate model than a murine one, to investigate the mechanisms of respiratory failure in DMD.

[1]  S. Binder-Macleod,et al.  Human skeletal muscle fiber type classifications. , 2001, Physical therapy.

[2]  B. Jasmin,et al.  Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. Nonaka,et al.  Canine X-linked muscular dystrophy in Japan (CXMDJ). , 2003, Experimental animals.

[4]  C. Reggiani,et al.  Respiratory muscle fibres: specialisation and plasticity , 2004, Thorax.

[5]  G. Butler-Browne,et al.  Analysis of skeletal and cardiac muscle from desmin knock-out and normal mice by high resolution separation of myosin heavy-chain isoforms. , 1996, Biology of the cell.

[6]  R. Billeter,et al.  No classical type IIB fibres in dog skeletal muscle , 2004, Histochemistry.

[7]  D. Allen,et al.  Different Pathways Regulate Expression of the Skeletal Myosin Heavy Chain Genes* , 2001, The Journal of Biological Chemistry.

[8]  I. Nonaka.  Animal models of muscular dystrophies. , 1998, Laboratory animal science.

[9]  B. Cooper,et al.  Canine X-linked muscular dystrophy: Selective involvement of muscles in neonatal dogs , 1991, Neuromuscular Disorders.

[10]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[11]  J. Léger,et al.  Expression of myosin heavy chain isoforms in Duchenne muscular dystrophy patients and carriers , 1991, Neuromuscular Disorders.

[12]  A. Nakamura,et al.  Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies , 2006, BMC cardiovascular disorders.

[13]  R. Matsuda,et al.  1-Syntrophin–deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration , 2002 .

[14]  R. Low,et al.  Changes in skeletal-muscle myosin isoenzymes with hypertrophy and exercise. , 1986, The Biochemical journal.

[15]  G. Butler-Browne,et al.  Myosin isozyme transitions occurring during the postnatal development of the rat soleus muscle. , 1984, Developmental biology.

[16]  H. Blau,et al.  Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy , 1988, Cell.

[17]  A. Gramolini,et al.  Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. , 2001, American journal of physiology. Cell physiology.

[18]  L. Morandi,et al.  Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expression , 1999, Acta Neuropathologica.

[19]  M. Crow,et al.  Chemical energetics of slow- and fast-twitch muscles of the mouse , 1982, The Journal of general physiology.

[20]  C. Reggiani,et al.  Fiber types in canine muscles: myosin isoform expression and functional characterization. , 2007, American journal of physiology. Cell physiology.

[21]  N. Vayssiere,et al.  Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice , 2004, Journal of Muscle Research & Cell Motility.

[22]  S. Takeda,et al.  Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products , 2007, Gene Therapy.

[23]  A. Simard,et al.  Calcineurin and skeletal muscle growth , 2002, Nature Cell Biology.

[24]  H. Sweeney,et al.  Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. , 1993, The American journal of physiology.

[25]  B. Kemp,et al.  Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice , 2006, Neuromuscular Disorders.

[26]  R. Abresch,et al.  Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[27]  R. Michel,et al.  Calcineurin Is Required for Skeletal Muscle Hypertrophy* , 1999, The Journal of Biological Chemistry.

[28]  A. Nakamura,et al.  Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ) , 2007, BMC musculoskeletal disorders.

[29]  B. Cooper,et al.  Canine X-linked muscular dystrophy: Morphologic lesions , 1990, Journal of the Neurological Sciences.

[30]  A. Nakamura,et al.  Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[31]  J. Terwilliger,et al.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. , 2001, Developmental biology.

[32]  D. Chemla,et al.  Myosin molecular motor dysfunction in dystrophic mouse diaphragm. , 1999, American journal of physiology. Cell physiology.

[33]  S. Fletcher,et al.  Use of the dog model for Duchenne muscular dystrophy in gene therapy trials , 1997, Neuromuscular Disorders.

[34]  F. Booth,et al.  Molecular regulation of individual skeletal muscle fibre types. , 2003, Acta physiologica Scandinavica.

[35]  S. Takeda,et al.  Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product , 2002, Gene Therapy.